Chinese Central Bank Steps Up Economic Support | The China Show 1/16/2026

Watch on YouTube ↗  |  January 16, 2026 at 05:36  |  1:34:25  |  Bloomberg Markets
Speakers
Wendell Huang — Vice President and CFO, TSMC
Ding X — Founder, Predict.fun
Winnie Wu — Head of A-PAC Equity Strategy, BofA Global Research
Abhishek Bishnoi — Senior Asia Equities Reporter
Michael Dang — Geoeconomics Technology Analyst
Annabel Droulers — Anchor, Bloomberg TV
Bing Wang — CFO
Kai Wang — Senior Equity Analyst, Morningstar
Yvonne Man — Head of APAC, CoinDesk
James Zimmerman — Chairman, AmCham China
Stephen Engle — Chief North Asian Correspondent, Bloomberg

Summary

The China Show focused on TSMC's blowout earnings and raised CapEx guidance, which reinforced the AI trade and Taiwan semiconductor supply chain outlook. China's PBOC announced targeted easing and signaled more room for policy support as loan demand remained weak, while Standard Chartered's Ding Shuang discussed RMB appreciation and bond-market implications. Other segments covered the US-Taiwan trade and chip investment deal, China's crackdown on high-frequency trading servers, Akeso's pipeline and FDA odds, Canada-China energy talks, and Morningstar's cautious view on Trip.com after its antitrust probe.

  • TSMC reported strong results and guided to $52-56 billion 2026 CapEx, boosting AI and semiconductor supply-chain sentiment.
  • The PBOC cut structural tool rates and flagged more easing room, but loan demand remained weak.
  • Standard Chartered expected gradual RMB appreciation, a Q2 policy-rate cut, a Q1 RRR cut, and bond-supportive liquidity operations.
  • The US-Taiwan trade deal lowered tariffs to 15% and clarified semiconductor tariff exemptions.
  • China regulators moved to remove high-frequency trading servers from exchange data centers, affecting global HFT firms.
  • Akeso highlighted ivonescimab FDA approval odds and a broad pipeline; Morningstar warned Trip.com faces antitrust and competition risks.
  • China and Canada discussed expanded energy cooperation, including oil, LNG, and batteries.
  • Asian markets were mixed but TSMC and China tech stocks remained in focus into the weekend.
Ideas
Wendell Huang Vice President and CFO, TSMC 0:34
TSMC Capex signals strong AI demand.
TSMC plans 2026 CapEx of $52-56 billion and total CapEx over the next three years significantly higher than the past three years, citing strong customer demand and conviction in the AI megatrend; leading-edge technology will remain in Taiwan for practical R&D and operations reasons.
Ding X Founder, Predict.fun 10:07
PBOC easing supports China government bonds.
The PBOC's 25bp cut to structural lending tools is small relative to total credit and mainly helps targeted sectors, while broader policy rate cuts are constrained by record-low bank net interest margins. Standard Chartered expects a 10bp policy rate cut in Q2 and a 25bp RRR cut in Q1, with liquidity injection and regular central government bond purchases aimed at preventing bond yields from rising, supporting Chinese government bonds.
Ding X Founder, Predict.fun 10:43
RMB set for gradual appreciation.
The PBOC appears more receptive to gradual renminbi appreciation, supported by China's fundamentals, technology and industrial upgrading, record trade and current-account surpluses, and the shift toward a strong-currency policy. A 2-3% appreciation would not undermine exports and could ease trade tensions.
Winnie Wu Head of A-PAC Equity Strategy, BofA Global Research 29:04
China equities have more upside room.
China's market performance could be front-loaded this year, supported by insurers allocating premiums into domestic equities, expectations of better US-China relations, the March Two Sessions and first year of the 15th five-year plan, and optimism over global AI and Chinese technology innovation. Foreign positioning is light, leaving room for global capital to increase allocations, though rotations and corrections warrant a barbell strategy.
Winnie Wu Head of A-PAC Equity Strategy, BofA Global Research 34:44
Thematic China baskets ease access.
Overseas investors often lack bandwidth to follow China's new leaders in high-tech infrastructure, humanoid robots/components, and innovative drugs, making thematic baskets such as Bank of America's China Innovation Basket and China humanoid robot basket easier ways to gain exposure. New IPOs also help because management is more willing to speak to global investors and improve disclosure.
Michael Dang Geoeconomics Technology Analyst 38:21
Trade deal clarifies Taiwan chip outlook.
The US-Taiwan trade deal lowers tariffs on Taiwanese goods to 15% and provides a concrete mechanism to exempt most semiconductors from Section 232 tariffs, reducing a major uncertainty and signaling continued US support for Taiwan. Semiconductors are Taiwan's biggest exports, so the clarity is positive for Taiwan's chip sector.
Abhishek Bishnoi Senior Asia Equities Reporter 50:00
TSMC remains core AI equity trade.
TSMC remains the core equity trade in Asia; its results and confident multi-year CapEx guidance show AI demand is a structural change rather than a normal cycle, and consensus earnings estimates are being revised upward with brokers upgrading price targets by 7-8%. The rotation away from TSMC is on the back burner.
Abhishek Bishnoi Senior Asia Equities Reporter 50:15
China, Korea, Taiwan favored over India.
China, Korea, and Taiwan remain the favored Asia markets in the AI/TSMC-led setup, while India is expected to continue underperforming even if absolute returns are positive.
Abhishek Bishnoi Senior Asia Equities Reporter 50:15
China, Korea, Taiwan favored over India.
China, Korea, and Taiwan remain the favored Asia markets in the AI/TSMC-led setup, while India is expected to continue underperforming even if absolute returns are positive.
Abhishek Bishnoi Senior Asia Equities Reporter 50:55
TSMC supply chain beneficiaries to gain.
TSMC's stronger CapEx and upward earnings revisions should flow through the wider semiconductor supply chain, especially Japanese semiconductor equipment makers and Malaysian chip testers.
Abhishek Bishnoi Senior Asia Equities Reporter 53:41
Buy China tech innovation dips.
China is not primarily a macro trade now; it is a technology innovation trade, and the regulatory clampdown on high-frequency trading servers is a minor market-structure change. Any market dip caused by that clampdown is a buying opportunity.
Akeso drug approval odds look good.
Akeso's PD-1/VEGF bispecific ivonescimab, partnered with Summit Therapeutics, has good FDA approval odds based on four successful Phase III studies and consistent safety/efficacy data. The company sees multiple 2026 catalysts, including potential US approval and additional indications, plus pipeline optionality in bispecific ADCs, immunology, and Alzheimer's.
Annabel Droulers Anchor, Bloomberg TV 72:47
TSMC margins show pricing power.
TSMC's earnings indicate genuine AI demand: 2026 sales growth around 30%, gross margin guidance of 63-65% above analyst estimates, and a raised long-term gross margin target from 53% to 56%. Strong capacity utilization and pricing power should help offset the cost of US investment.
Annabel Droulers Anchor, Bloomberg TV 79:52
Taiwan dollar may face pressure.
TSMC's large US investment commitments under the new Taiwan-US trade pact could pressure the Taiwanese dollar this year, especially after the currency was already a major headwind last year. The scale of dollar outflows to the US makes TWD weakness worth watching.
Yvonne Man Head of APAC, CoinDesk 86:12
Yen weakness likely to persist.
The yen remains weak because fiscal stimulus, BOJ uncertainty, and election risks keep positive real-yield catalysts from materializing, and market forces may continue to pressure it. Japanese officials are warning about one-sided moves and intervention risk, making JPY a key watch.
Kai Wang Senior Equity Analyst, Morningstar 89:01
Trip.com faces antitrust margin risk.
Chinese regulators are investigating Trip.com over exclusive merchant contracts and high commissions. While its narrow moat may remain intact, the probe could open travel-platform competition from larger internet conglomerates like Alibaba and Tencent and lead to long-term margin pressure, so the valuation faces more risk.
Up Next

This Bloomberg Markets video, published January 16, 2026, features Wendell Huang, Ding X, Winnie Wu, Michael Dang, Abhishek Bishnoi, Bing Wang, Annabel Droulers, Yvonne Man, Kai Wang discussing TSM, CBON, CNY, FXI, China Innovation Basket, China humanoid robot basket, Taiwan semiconductors, EWY, EWT, India Equities, Japan semiconductor equipment, Malaysia chip testers, Akeso, SMMT, TWD, JPY, TCOM. 16 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Wendell Huang, Ding X, Winnie Wu, Michael Dang, Abhishek Bishnoi, Bing Wang, Annabel Droulers, Yvonne Man, Kai Wang  · Tickers: TSM, CBON, CNY, FXI, China Innovation Basket, China humanoid robot basket, Taiwan semiconductors, EWY, EWT, India Equities, Japan semiconductor equipment, Malaysia chip testers, Akeso, SMMT, TWD, JPY, TCOM